https://www.selleckchem.com/pr....oducts/Rutin(Rutosid
Results Ten gait characteristics significantly progressed in PD, with changes in four of these characteristics attributable to disease progression. Age-related changes also contributed to gait progression; changes in another two characteristics reflected both aging and disease progression. Gait impairment progressed irrespective of dopaminergic medication change for all characteristics except step width variability. Conclusions Discrete gait impairments continue to progress in PD over 6 years, reflecting a combination of, and po
Like
Comment
Share
